Interview: Analysing the potential for DNA vaccines

Dr. Niranjan Sardesai, Chief Operating Officer, Inovio Pharmaceuticals was kind enough to take the time to speak to us to give his viewpoint on DNA Vaccines, in particular, their potential across a range of cancer indication. What is the potential for DNA vaccines across a broad range of cancer indications? It’s a great time to be in the DNA vaccine arena. There’s a …

The Future of DNA Vaccines

In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Tony Ford-Hutchinson, Merck entitle ‘The Future of DNA Vaccines' This presentation outlines: Vaccines Have Made a …

Pneumococcal Conjugate Vaccine for Adults: A New Paradigm

  In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by William Gruber, Pfizer entitled: ‘Pneumococcal Conjugate Vaccine for Adults: A New Paradigm'This presentation outlines: Efficacy …

Presentation: Vaccine development using two immunopotent viral vectors

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Sarah Gilbert from The Jenner Institute entitiled: ‘Vaccine development using two immunopotent viral vectors; …

Immunization Strategies for the Developing World

The second morning session of Day One at the World Vaccine Congress USA 2013 started with Dr John Boslego, Global Program Leader, Vaccine Development at PATH, delivering a talk entitled ‘Driving the development of much needed vaccines for the developing world'. He spoke about the work of PATH, and introduced the 3 pillars of PATH – namely 1) Advancing technologies, …

Global Immunization Strategies and Initiatives

Day One of the World Vaccine Congress USA 2013 got underway with an introductory speech from Neil Darkes, General Manager of the Life Sciences division at Terrapinn. Neil introduced Dr George Siber, Executive Chairman of Genocea, who welcomed us all to the 13th vaccine congress, and gave us some food for thought by asking the question: which 3 interventions have …

Academic and industrial collaboration: Developing a Td and Tdap vaccine in collaboration with Green Cross

In the upcoming World Vaccine Congress Asia 2013, Professor Kang Jin Han will be joining us as one of the speakers. Hear more about developing a Td and Tdap vaccine as he tells us more about the academic and industrial collaboration with Green Cross. He will be reviewing epidemiology of tetanus, diphtheria and pertussis in Korea and the opportunities for …

Eliminating vaccine-preventable diseases in Asia: Response to vaccine security and self-reliance in Asia

While vaccines have gradually reduced or eliminated various infectious diseases, the viruses and bacteria that cause vaccine-preventable diseases still exist, posing a threat to those without access to vaccines. At World Vaccine Congress Asia 2013 , this coming June, Dr. Charung Muangchana will be giving insights on eliminating these vaccine-preventable diseases, focusing specifically on the response to vaccine security and …